Stay updated with breaking news from Normal Hematopoietic Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acute myeloid leukemia (AML) is an aggressive blood cancer that causes uncontrolled accumulation of white blood cells. Researchers at Baylor College of Medicine and collaborating institutions report they have uncovered a new vulnerability of this cancer that can be targeted with a class of experimental drugs.
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting News provided by Share this article Share this article SAN DIEGO, April 27, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced three data presentations to be delivered at the upcoming American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting, being held virtually May 11-14, 2021. Poseida ...